Oskar Ayerdi , Eva Orviz , Adrián Valls Carbó , Nuria Fernández Piñeiro , Mar Vera García , Teresa Puerta López , Juan Ballesteros Martín , Carmen Rodríguez Martín , Begoña Baza Caraciolo , Clara Lejarraga Cañas , Jorge-Alfredo Pérez-García , Dulce Carrió , Mónica García Lotero , María Ferreras Forcada , Montserrat González Polo , Montserrat Raposo Utrilla , Alberto Delgado-Iribarren , Jorge Del Romero-Guerrero , Vicente Estrada Pérez
{"title":"Incidencia de infecciones de transmisión sexual y modelos de cribado entre usuarios de profilaxis preexposición frente al VIH","authors":"Oskar Ayerdi , Eva Orviz , Adrián Valls Carbó , Nuria Fernández Piñeiro , Mar Vera García , Teresa Puerta López , Juan Ballesteros Martín , Carmen Rodríguez Martín , Begoña Baza Caraciolo , Clara Lejarraga Cañas , Jorge-Alfredo Pérez-García , Dulce Carrió , Mónica García Lotero , María Ferreras Forcada , Montserrat González Polo , Montserrat Raposo Utrilla , Alberto Delgado-Iribarren , Jorge Del Romero-Guerrero , Vicente Estrada Pérez","doi":"10.1016/j.eimc.2024.01.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>There is discussion about the frequency of STI screening among pre-exposure prophylaxis (PrEP) users. The aim of this study was to analyze the incidence of STIs and to evaluate different screening models in order to optimize the follow-up.</div></div><div><h3>Methodology</h3><div>A prospective study was conducted between 2017 and 2023, including 138 PrEP users in a STI clinic. Participants were tested for STIs every three months. Unscheduled visits were performed for those with STI-related symptoms or for people who were notified for an STI by a sexual partner. We performed a survival analysis of repeated events, estimating the cumulative incidence (<span>C</span>I) and incidence rate (IR).</div></div><div><h3>Results</h3><div>The overall CI by quarterly screening was 8.3 (95% CI: 7.6–9.1) infections per person over six years, with a decreasing trend. The most frequently diagnosed pathogen was <em>Neisseria gonorrhoeae</em>, with a IR of 0.76 (95% CI: 0.68–0.84). If the frequency of screening is reduced to every six months, the IR of STIs is reduced by (95% CI: 0.5–0.66) infections per user per year, and at 12 months by 0.82 (95% CI: 0.73–0.89). In the case of no pharyngeal or urethral screening, IR is reduced by 0.37 (95% CI: 0.32–0.42) infections per person per year and in those over 35 years of age by 0.33 (95% CI: 0.25–0.4). Eliminating unscheduled visits, the reduction in IR is 0.33 (95% CI: 0.24–0.42).</div></div><div><h3>Conclusions</h3><div>The incidence of STIs among PrEP users is high, especially in the rectum, but it does not increase over time. STI screening could be optimized reducing the frequency of pharyngeal and urethral testing, particularly in those over 35 years of age. It is essential to redistribute health resources for unscheduled visits, which have been shown to be the most cost-effective screening.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 10","pages":"Pages 570-576"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213005X24001903","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
There is discussion about the frequency of STI screening among pre-exposure prophylaxis (PrEP) users. The aim of this study was to analyze the incidence of STIs and to evaluate different screening models in order to optimize the follow-up.
Methodology
A prospective study was conducted between 2017 and 2023, including 138 PrEP users in a STI clinic. Participants were tested for STIs every three months. Unscheduled visits were performed for those with STI-related symptoms or for people who were notified for an STI by a sexual partner. We performed a survival analysis of repeated events, estimating the cumulative incidence (CI) and incidence rate (IR).
Results
The overall CI by quarterly screening was 8.3 (95% CI: 7.6–9.1) infections per person over six years, with a decreasing trend. The most frequently diagnosed pathogen was Neisseria gonorrhoeae, with a IR of 0.76 (95% CI: 0.68–0.84). If the frequency of screening is reduced to every six months, the IR of STIs is reduced by (95% CI: 0.5–0.66) infections per user per year, and at 12 months by 0.82 (95% CI: 0.73–0.89). In the case of no pharyngeal or urethral screening, IR is reduced by 0.37 (95% CI: 0.32–0.42) infections per person per year and in those over 35 years of age by 0.33 (95% CI: 0.25–0.4). Eliminating unscheduled visits, the reduction in IR is 0.33 (95% CI: 0.24–0.42).
Conclusions
The incidence of STIs among PrEP users is high, especially in the rectum, but it does not increase over time. STI screening could be optimized reducing the frequency of pharyngeal and urethral testing, particularly in those over 35 years of age. It is essential to redistribute health resources for unscheduled visits, which have been shown to be the most cost-effective screening.
期刊介绍:
Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.